As of 2026-03-22, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 17.2x | 16.2x |
| Forward P/E multiples | 15.5x - 21.8x | 18.7x |
| Fair Price | (67.12) - (73.75) | (74.74) |
| Upside | -197525.2% - -217025.8% | -219927.7% |
| Date | EV/EBITDA |